Business Context and Reporting Period
This Form 8-K, dated May 12, 2022, is filed by Data Knights Acquisition Corp. (DKDC), a Delaware corporation and emerging growth company. The filing discloses the entry into a definitive Agreement and Plan of Merger on April 25, 2022, with OneMedNet Corporation, Inc. (OneMedNet). Under the terms of the agreement, Data Knights Merger Sub, Inc. will merge with and into OneMedNet, resulting in OneMedNet becoming a wholly-owned subsidiary of Data Knights Acquisition Corp. The filing includes an investor presentation (Exhibit 99.1) but explicitly states it is not a proxy statement or an offer to sell securities.
Key Financial Metrics
The filing text does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity for either Data Knights Acquisition Corp. or OneMedNet. The document serves as a notification of the merger agreement and references an investor presentation for further details, but the presentation itself is not included in the provided text. Consequently, no numerical financial data can be extracted from this source.
Material Changes
The primary material change reported is the execution of the Merger Agreement with OneMedNet Corporation, Inc. This transaction represents a significant shift in the registrant's business strategy from a special purpose acquisition company (SPAC) seeking a target to a company with a definitive business combination plan. The filing notes that the transaction is subject to stockholder approval and other customary closing conditions.
Guidance, Outlook, and Risks
Outlook and Guidance: The filing contains forward-looking statements regarding the likelihood of consummating the transaction, the implied enterprise value, and the expected ownership structure. However, it explicitly disclaims any obligation to update these statements and notes that projected numbers are for illustrative purposes only.
Risks and Contingencies: Management highlights several material risks that could prevent the transaction from closing or adversely affect the company:
- Failure to complete the transaction by the Business Combination deadline or inability to obtain an extension.
- Failure to satisfy conditions, including stockholder adoption, minimum cash requirements following redemptions, and regulatory approvals.
- Lack of a third-party valuation for the transaction.
- Disruption to OneMedNet's business relationships and operations during the pendency of the deal.
- Volatility in the price of the Company's securities.
- Risks related to OneMedNet's ability to develop and commercialize products, achieve profitability, or raise additional capital.
Investor Verification Checklist
- Verify the definitive terms of the Merger Agreement, including the exchange ratio and implied valuation, in the upcoming Prospectus and Proxy Statement.
- Confirm the minimum cash amount required to close the transaction and the potential impact of public stockholder redemptions.
- Review the financial performance and projections of OneMedNet Corporation, Inc., which are not detailed in this 8-K.
- Monitor the status of regulatory approvals and the timeline for the stockholder vote.
- Assess the risk of the transaction failing to close by the Business Combination deadline.